Skip to main content
Novartis AG
Healthcare · Drug Manufacturers - General
Made on Jul 31, 2026
Price at call $158.44
6-month call Bull +8.9%
Target by Jan 2027 $172.50
Great value below $140.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change +8.9% to $172.50
Predicted High $172.50 at 6 months
Predicted Low $159.20 in 2 weeks

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Jul 31, 2026 2:07 am
Bull NVS trends higher to $172.50 (+8.9% from $158.44) by Jan 2027. dip-then-recover
ThesisNVS is a low-beta Swiss compounder trading below multiple fair-value anchors with quality confirmed and sentiment quietly constructive. Expect a gradual grind higher toward the composite fair value zone, with value gravity dominating over the 6-month horizon rather than any single catalyst.
Invalidated ifA break below $150 on pipeline setback or LOE surprise, or failure to reclaim $165 by m3, would invalidate the drift-higher thesis.
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $158.44 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Jul 31, 2026 $158.44 at call The anchor — every point below is measured from this price and date.
2 weeks Aug 14, 2026 $150.52–$166.36 typical range · internal point $159.20 ±5.0% 6/10 Low-vol drift, neutral regime, no near catalyst
What actually happened: closed $151.72 on Aug 13, 2026 = -4.2% vs the call (predicted +0.5%)  ·  direction HIT (called flat, was flat)  ·  off by 4.7 pp  ·  accuracy 8/10  ·  typical range ±5.0%: inside the band  ·  S&P +4.1% over the same window — beat it
1 month Aug 31, 2026 $146.96–$169.92 typical range · internal point $160.10 ±7.2% 6/10 Quiet summer tape, mild mean reversion higher
2 months Oct 1, 2026 $162.50 +2.6% 5/10 Approaching Q3 print, positioning into results
3 months Oct 31, 2026 $164.80 +4.0% 5/10 Earnings digestion, value anchor pull activates
4 months Dec 1, 2026 $167.20 +5.5% 4/10 Year-end rotation into defensive quality names
5 months Dec 31, 2026 $170.00 +7.3% 4/10 Composite fair value gravity, low-beta bid
6 months Jan 31, 2027 $172.50 +8.9% 4/10 Convergence toward baseline, sentiment steady

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $175.62 (+10.8%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

No weaknesses recorded for this run.

All inputs present, no fallbacks used — nothing to flag.

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$158.44
Composite fair value$165.15
Signal-adjusted fair value$200.07
DCF fair value$196.94
Anchored-PE fair value$180.97
Buy-below (value lens)$140.00
Value net score+14
Value confidence6 / 10
Quality net score+71
Memo confidence7 / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 26.8%  3m 25.1%  6m 23.1%  
Daily σ (realism noise)1.6%
Beta vs S&P 500 1m -0.18  3m 0.08  5m 0.41  
Trailing 6-month return7.1%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Jul 30, 2026 freshest NVS-20260730-203014-f2ab
ext-forensic-memo Jul 30, 2026 freshest ext-NVS-20260730-215658-4b99
ext-lens-quality Jul 30, 2026 freshest ext-NVS-20260730-215658-4b99
ext-lens-sentiment Jul 30, 2026 freshest ext-NVS-20260730-215658-4b99
ext-lens-value Jul 30, 2026 freshest ext-NVS-20260730-215658-4b99
scenario-valuation Jul 30, 2026 freshest NVS-20260730-211427-77cc
valuation-synthesis Jul 30, 2026 freshest NVS-20260730-211427-77cc

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

2 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 23, 2026 v0.6.0 Bull $158.86 $173.00 +8.9% Feb 2027 view
Jul 31, 2026 v0.6.0 Bull $158.44 $172.50 +8.9% Jan 2027 viewing

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.